Introduction
============

Preventable postsurgical complications are increasingly recognized as a major healthcare burden. A recent meta-analysis showed a 17 to 29% decrease in complications after major surgery with perioperative goal-directed therapy (PGDT) \[[@B1]\]. We assessed the financial consequences of postsurgical complications in a large population from 541 US hospitals in order to predict potential savings with PGDT.

Methods
=======

Data from adults who had any one of 10 major noncardiac surgical procedures between January 2011 and June 2013 were selected from the Premier research database. Twenty-six postsurgical complications were tabulated. Hospital costs, length of stay, and readmission rates were compared in patients with and without complications. Risk ratios reported by Pearse\'s meta-analysis were used to estimate the expected reduction in postsurgical morbidity with PGDT. Potential cost-savings were calculated from the actual and anticipated morbidity rates using the mean difference in total costs.

Results
=======

A total of 204,680 patients met the search criteria, and 76,807 patients developed one or more postsurgical complications (morbidity rate 37.5%). In patients with and without complications, hospital costs (including 30 days readmission costs) were \$27,607 ± 32.788 and \$15.783 ± 12,282 (*P*\< 0.0001), median (interquartile range) hospital lengths of stay (first stay) were 7 (4 to 10) days and 4 (3 to 5) days (*P*\< 0.0001), and 30-day readmission rates were 17.2% and 11.9% (*P*\< 0.0001), respectively. With PGDT, the morbidity rate was anticipated to decrease from 26.6 to 31.1%, yielding gross cost savings of \$153 million to 263 million for the study period, \$61 million to 105 million per year, or \$754 to 1,286 per patient.

Conclusion
==========

Postsurgical complications occurred in more than one-third of our study population and had a dramatic impact on hospital costs, length of stay, and readmission rates. Potential cost savings with PGDT were \$754 to 1,286 per patient. These projections should help hospitals estimate the return on investment for implementation of PGDT.
